Vol 15, No 4 (2014)

Table of Contents

Editorial

The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014
Mario Eandi
HTML PDF
97-98

Original research

Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro
HTML PDF
101-112
Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
Daniela Paola Roggeri, Alessandro Roggeri, Vittorio Pengo
HTML PDF
113-127
Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy
Alberto Migliore, Andrea Belisari, Lucia S. D'Angiolella, Emanuele Bizzi, Umberto Massafra, Prisco Piscitelli, Lorenzo Giovanni Mantovani
HTML PDF
139-146
How do European patients feel about the listening skills of primary care physicians? Results from the EUprimecare Project
Carlos Alberto Sánchez Piedra, Sonia García-Pérez, Francisco Javier Prado-Galbarro, Antonio Sarría-Santamera
HTML PDF
147-153
Pharmacoeconomic aspects related to the 13-valent pneumococcal conjugate vaccine: preliminary analysis of the data from the ASL of Viterbo
Silvia Dari, Flavia Verginelli, Silvia Aquilani
HTML PDF
155-159

Review (Economic Analysis)

Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration
Piergiorgio Neri, Ilir Arapi, Chiara Maria Eandi, Vittorio Pirani, Cesare Mariotti, Alfonso Giovannini
HTML PDF
129-138